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Abstract 
Increased microvascular permeability to plasma proteins and neutrophil emigration are hallmarks of 
innate immunity and key features of numerous inflammatory disorders. Whilst neutrophils can 
promote microvascular leakage, the impact of vascular permeability on neutrophil trafficking is 
unknown. Here, through the application of confocal intravital microscopy, we reported that vascular 
permeability enhancing stimuli caused a significant frequency of neutrophil reverse transendothelial 
cell migration (rTEM). Furthermore, mice with a selective defect in microvascular permeability 
enhancement (VEC-Y685F-ki) showed reduced incidence of rTEM. Mechanistically, elevated 
vascular leakage promoted movement of interstitial chemokines into the blood stream, a response 
that supported abluminal-to-luminal neutrophil TEM. Through development of an in vivo cell labelling 
method we provided direct evidence for the systemic dissemination of rTEM neutrophils, showed 
them to exhibit an activated phenotype and capable of trafficking to the lungs where their presence 
was aligned with regions of vascular injury. Collectively, we demonstrated that increased 
microvascular leakage reverses the localisation of directional cues across venular walls, thus causing 
neutrophils engaged in diapedesis to re-enter the systemic circulation. This cascade of events offers 
a mechanism to explain how local tissue inflammation and vascular permeability can induce 
downstream pathological effects in remote organs, most notably in the lungs.   
3 
 
Introduction 
Acute inflammation is a critically important pathophysiological response to a local stimulus (e.g. 
bacterial infection) characterised by local tissue infiltration of neutrophils and tissue swelling 
(oedema). These responses typically begin within minutes after a stimulus and collectively support 
the activation of essential immunoregulatory, pro-inflammatory and pro-resolution pathways required 
for effective host defence and tissue repair. Excessive and/or inappropriately triggered neutrophil 
migration and increased vascular leakage can also be the underlying cause of a vast range of acute 
and chronic inflammatory disorders, such as acute lung injury and rheumatoid arthritis, and are as 
such well-established anti-inflammatory therapeutic targets (1, 2). Central to regulation of these 
responses are endothelial cells (ECs) that line the inner aspect of all blood vessels and provide the 
principal barrier to migrating immune cells and blood-borne macromolecules. With respect to 
neutrophil trafficking, ECs provide critical pro-adhesive and other effector molecules that facilitate a 
cascade of neutrophil-EC interactions, such as neutrophil rolling, firm arrest and luminal crawling, 
events that are generally considered to be pre-requisite to breaching of the endothelium (3). 
Transendothelial cell migration (TEM) is supported by an array of EC junctional molecules, most 
notably PECAM-1 (CD31), members of the junctional adhesion molecule (JAM) family, VE-cadherin 
and others (3-5). In addition, we recently demonstrated the importance of retaining directional cues 
within EC junctions in facilitating luminal-to-abluminal neutrophil breaching of the endothelium (6).   
With respect to vascular leakage, under basal conditions the microvascular endothelium has a low 
permeability to plasma proteins, and as such establishes an oncotic gradient that opposes the 
vascular hydrostatic pressure that would otherwise excessively move water and solutes into the 
tissue. This situation rapidly changes in inflammation, enabling immediate supply of plasma proteins 
(e.g. complement components and antibodies) to injured or infected organs through increased 
permeability of the vascular endothelium (7). Leakage of macromolecules in inflammation largely 
occurs via a paracellular route involving loosening of EC junctions (5, 7, 8) mediated via actinomyosin-
based contraction of ECs and destabilisation of junctional contacts. The latter most notably involves 
down-regulation of the adhesive functions of VE-cadherin (5, 8) with inflammation-induced increased 
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vascular permeability being associated with elevated tyrosine phosphorylation of components of the 
VE-cadherin-catenin complex (5, 9). Of particular significance, investigations using knock-in mice 
expressing specific point mutations in VE-cadherin tyrosine residues (i.e. VEC-Y685F and VEC-
Y713F), have categorically identified distinct molecular mechanisms in governing the passage of 
neutrophils and macromolecules through EC junctions (9). These findings are in line with early 
seminal works that definitively uncoupled in a temporal and spatial manner leukocyte extravasation 
from increased vascular permeability (10, 11).  
Despite this, the close association of stimulated neutrophil transmigration and vascular permeability 
has historically attracted much attention towards their potential interplay, and indeed, it is now 
generally accepted that neutrophils can promote microvascular leakage in the early stages of an acute 
inflammatory response (12, 13). However, whether vascular permeability can regulate neutrophil 
migration remains poorly investigated and is contentious. To address this fundamental element of 
acute inflammation we used confocal intravital microscopy (IVM) to simultaneously analyse vascular 
leakage and neutrophil trafficking in inflamed tissues. Increased microvascular leakage did not 
influence the overall magnitude of neutrophil infiltration into tissues over several hours. Surprisingly 
however, leaky microvessels promoted a rapid and significant frequency of neutrophil reverse 
transendothelial cell migration (rTEM; ~20-40%) in the early phases of hyperpermeability reactions. 
This aberrant behaviour was caused by an immediate increase in diffusion of interstitial chemokines 
into the vascular lumen, a response that disrupted the correct localisation of chemotactic cues within 
the venular wall niche. Furthermore, through development of an in vivo cell labelling method, we 
provide direct evidence for the ability of rTEM neutrophils that have stemmed from an inflammatory 
vascular leakage site to traffic to the lungs. Functionally, rTEM neutrophils were activated, and their 
presence within the pulmonary vasculature was aligned with sites of vascular injury, suggesting a 
pathological role for this sub-set of neutrophils. Collectively by identifying that local microvascular 
leakage induction facilitates movement of interstitial chemokines through EC junctions and entry into 
the vascular lumen, we have discovered an additional mechanism for promotion of neutrophil rTEM 
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in vivo. Importantly, our findings directly link this cascade of events with the capacity of local 
hyperpermeability reactions to elicit remote organ damage.   
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RESULTS  
Leaky venules support neutrophil reverse TEM 
To directly investigate potential associations between neutrophil trafficking and microvascular 
permeability, inflamed mouse cremaster muscles were analysed for neutrophil breaching of EC 
junctions and microvascular leakage in real-time and in 3D (i.e. 4D) by confocal IVM. Briefly, the 
model employs LysM-EGFP-ki mice in conjunction with in vivo labelling of EC junctions using locally-
applied non-blocking AlexaFluor-647 labelled (AF647) anti-CD31 mAb (14). Neutrophil TEM was 
analysed through tracking of GFPbright neutrophils, and microvascular leakage was quantified by 
measuring interstitial accumulation of intravenously injected plasma protein tracer TRITC-dextran 
(MW ~75kDa) (Figure 1A and Supplemental movie 1). In initial studies we analysed inflammatory 
responses induced by local injections of LTB4 and IL-1 and by a local pathophysiological insult of 
ischemia-reperfusion (IR) injury (all within 2-4h). Whilst these acute reactions elicited significant and 
comparable levels of total neutrophil infiltration into tissues within the overall test periods, as 
compared to control responses (Figure 1B), marked and rapid increased vascular leakage was only 
detected in tissues stimulated with LTB4 and IR (Figure 1C). Of note, overtime hyperpermeability 
reactions were associated with uptake of tissue infiltrated dextran by perivascular cells (Figure 1A) 
but these regions were excluded from the image analysis process. 
Most importantly, in contrast to the normal neutrophil TEM observed in IL-1-stimulated tissues (i.e. 
neutrophils breaching EC junctions in a luminal-to-abluminal direction and without pause; Figure 1D 
and Supplemental movie S2), inflammatory reactions that increased vascular leakage were 
associated with the occurrence of neutrophil reverse TEM (rTEM) (Supplemental movie S3). 
Specifically, in LTB4- and IR-stimulated tissues, and in line with our previous reports (14, 15), a 
significant proportion of neutrophils that initiated TEM by extending protrusions through EC junctions 
rapidly retracted their cell body, exhibited reverse motility through EC junctions, and ultimately 
returned back into the blood circulation (Figure 1D). This mode of neutrophil TEM accounted for ~20-
40% of all TEM events driven by LTB4 and IR but was rarely seen in IL-1-stimulated tissues (<5%) 
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(Figure 1E). Using the IR reaction to analyse the onset of this phenomenon we noted that ~62% of 
the rTEM events occurred within the first 10min of the reperfusion phase (Figure 1F). In contrast, 
normal neutrophil TEM, as indicated via neutrophil accumulation in the perivascular tissue, was more 
sustained and continued to develop over the 2h reperfusion period analysed (data not shown). Of 
significance, whilst a close temporal association was observed between dextran leakage and 
frequency of neutrophil rTEM, the former exhibited an earlier onset (i.e. within less than 5min post 
reperfusion, Figure 1F). This raised the possibility that increased EC permeability can influence the 
directionality of neutrophil TEM, prompting us to investigate the impact of vascular leakage enhancing 
stimuli, histamine and VEGF-A164 (VEGF) on rTEM.  
In agreement with previously published reports (16, 17), topical application of histamine to exteriorised 
cremaster muscles promoted neutrophil rolling but failed to induce neutrophil firm arrest or 
transmigration (Supplemental Figure 1A-C). Similarly, topical application of histamine to exteriorised 
IL-1-stimulated cremaster muscles caused no significant increase in neutrophil adhesion or 
transmigration beyond that seen with IL-1 alone (Supplemental Figure 1D and Figure 2A). As 
anticipated, topical histamine induced a marked vascular leakage response in IL-1-treated tissues 
as compared to tissues treated with just IL-1 or PBS (Figures 2B, C and Supplemental movie S4), 
however, most intriguingly, it promoted a significant frequency of neutrophil rTEM events (~20%; 
Figure 2D and Supplemental movie 4). Similarly, whilst i.v. VEGF induced a notable vascular leakage 
response in mice treated with local IL-1 (Supplemental Figure 1E) without impacting total neutrophil 
infiltration (Supplemental Figure 1F), it caused a dramatic increase in frequency of neutrophil rTEM 
(~25%; Figure 2D). Furthermore, in animals treated with IL-1+histamine, maximal neutrophil rTEM 
was again detected rapidly post topical application of histamine (~80% within 20min), in line with the 
rapid stimulated vascular leakage (Figure 2E). Collectively, the present findings demonstrate a 
previously unappreciated link between induction of vascular leakage and aberrant neutrophil TEM 
with the induction of leakage emphatically impacting the directional migration of neutrophils through 
EC junctions. 
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Genetic defect in microvascular leakage suppresses neutrophil reverse TEM  
To further investigate the causal link between increased microvascular leakage and disrupted 
neutrophil TEM, we took advantage of a knock-in mouse model that expresses a Y685F mutant of 
VE-cadherin (VEC-Y685F) and shows reduced vascular leakage but normal neutrophil extravasation 
(9). Knock-in mice expressing wild-type (WT) VE-cadherin (VEC-WT) were used as controls. To 
facilitate simultaneous quantification of neutrophil TEM dynamics and vascular leakage, chimeric 
mice were generated through adoptive transfer of bone-marrow from LysM-EGFP-ki donor mice into 
irradiated VEC-WT and VEC-Y685F recipients (Figure 3A). Using our model of local IL-1+histamine, 
VEC-Y685F chimeric mice showed reduced (~26%) interstitial dextran accumulation (Figure 3B and 
C) with no significant change in total neutrophil extravasation over 2h (Figure 3D), as compared to 
responses detected in chimeric VEC-WT controls. These results are in line with the findings of Wessel 
and colleagues using the Miles assay in which 36% suppression of histamine-induced vascular 
leakage was detected in the dorsal skin of VEC-Y685F mice (9). Of note, in agreement with our 
previous results (Figure 2D), IL-1+histamine caused a substantial frequency of neutrophil rTEM 
(~22%; Figure 3E) in VEC-WT chimeric mice. However, mice harbouring the mutant form of VE-
cadherin exhibited a significantly reduced frequency of this response (down to ~10%), culminating in 
~55% inhibition of rTEM as compared to VEC-WT mice (Figure 3E). Together, our results provide 
compelling evidence for the ability of increased vascular leakage to disrupt luminal-to-abluminal 
motility of neutrophils through EC junctions resulting in neutrophil reverse TEM back into the vascular 
lumen.  
 
Microvascular leakage promotes trafficking of interstitial chemokines into the blood stream 
We next explored the mechanism through which vascular leakage induction promotes disrupted 
directionality of neutrophil TEM. Since our earlier works identified reduced EC junctional expression 
of JAM-C as a driver of incomplete and reverse modes of neutrophil TEM (14, 15), this possibility was 
evaluated in the context of vascular leakage. However, local histamine, IL-1, or the combination of 
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both mediators had no impact on expression of EC JAM-C (Supplemental Figure 2). In considering 
alternative mechanisms, we hypothesised that elevated microvascular permeability may alter the local 
chemotactic gradient across venular walls. To explore this notion, since IL-1 is an effective inducer 
of a potent neutrophil chemokine CXCL1 (18, 19), we sought to investigate the impact of increased 
vascular leakage on generation and localisation of CXCL1 in IL-1-stimulated tissues.   
IL-1-stimulation of WT cremaster muscles led to a robust increase in tissue and plasma CXCL1, as 
compared to PBS-treated mice (Figure 4A-D). Whilst locally injected histamine or i.v. VEGF had no 
significant effect on IL-1-induced tissue levels of CXCL1, they elevated the associated plasma levels 
of CXCL1 (Figure 4A-D). Of note, the vasoactive agents on their own did not induce either tissue or 
plasma CXCL1 (Figure 4A-D). Similarly, as found with IL-1, TNF stimulation of cremaster muscles 
increased tissue and plasma CXCL1, with the latter being further elevated after local administration 
of histamine (Figure 4A and B). In addition, increased tissue and plasma CXCL1 were detected in 
mice subjected to the hyperpermeability-inducing reaction of cremasteric IR injury (Supplemental 
Figure 3). These results imply that vascular permeability enhancing stimuli can promote the trafficking 
of endogenously generated CXCL1 from the tissue into the blood stream. To directly investigate this 
possibility, we asked a general but fundamental question: can an extravascular protein, comparable 
to the size of a chemokine (~8kDa), traffic into the blood stream through hyperpermeable leaky 
microvessels? To address this, we examined by confocal IVM the localisation of topically-applied 
small molecular weight (10kDa) AF488-dextran in control and histamine-treated IL-1-stimulated 
cremaster muscles. Here, vascular leakage was simultaneously quantified using i.v. injected high 
molecular weight (75kDa) TRITC-dextran. Superfusion of exteriorised cremaster muscles with 10kDa-
AF488-dextran (for 10min) led to its rapid and sustained accumulation in the extravascular space 
surrounding blood vessels (Figure 4E and F and Supplemental movie 5). Topical application of 
histamine caused immediate leakage of blood-circulating 75kDa-TRITC-dextran into the interstitium 
(Figure 4E and G and Supplemental movie 5), confirming induction of vascular leakage. Importantly, 
this effect was associated with rapid (<5min) disappearance of the 10kDa-AF488-dextran signal from 
the perivascular space, as compared to tissues treated with topical vehicle (Figure 4E, F and G). 
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Furthermore, in mice treated with topical histamine, a significant level of 10kDa-AF488-dextran was 
detected in plasma (Figure 4H).  
Collectively these results demonstrate that under conditions of enhanced vascular permeability, a 
small MW protein can diffuse from the interstitium into the blood stream against an advective flow in 
the opposite direction. As seemingly unexpected, further validation of these experimental findings 
were sought through mathematical modelling. Briefly, as the molecular flux across the vessel wall is 
determined by a combination of diffusive and advective transport, for a small MW protein in the 
extravascular compartment (e.g. 10kDa dextran or a chemokine) to enter the blood circulation, the 
diffusive flux from tissue to blood must be high enough to overcome the opposing advective flux 
(Figure 4I). This ratio is defined by the Péclet number (Pe) (Figure 4I). If the Pe is substantively less 
than 1, then there can be diffusion against an advective flow of fluid. If the Pe is >1 then diffusion 
cannot effectively oppose filtration – in other words for a molecule to diffuse against a flow of fluid Pe 
needs to be <1. Using previously published values for the hydraulic conductivity properties of ECs, 
and known diffusion coefficients, the Pe number for a 10kDa dextran in cremaster muscle 
microvessels is calculated to be ~0.8 under normal conditions (Supplemental Figure 4). Such a 
scenario would allow some diffusion of interstitial protein into the vascular lumen, in line with our 
experimental data (Figure 4H). However, under conditions of increased vascular permeability (e.g. as 
induced by local histamine) this falls substantially to values at which diffusion dominates advective 
flux (i.e. Pe<0.3; Figure 4I and Supplemental Figure 4). This modelling of the molecular flux across 
cremasteric venular walls supports our experimental data and provides additional endorsement for 
the concept that vascular hyperpermeability can facilitate the trafficking of extravascular small 
molecules into the vascular lumen. 
We next directly assessed the capacity of an interstitial chemokine to engage with EC junctions and 
to leak from the tissue into the bloodstream post vascular permeability induction. For this purpose, 
we analysed the localisation of human CXCL8 (hCXCL8) in relation to ECs, when locally applied to 
IL-1-stimulated cremaster muscles, in the presence or absence of histamine. Although in control 
tissues the chemokine was modestly aligned with the endothelium, this was significantly elevated post 
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local application of histamine, most notably in relation to EC junctions (Figure 5A and B). Furthermore, 
whilst locally injected hCXCL8 could be detected in plasma of mice treated with IL-1only, this 
response was significantly increased (~42%) in mice treated with IL-1+histamine (Figure 5C). A 
similar increase in plasma levels of locally injected hCXCL8 was noted in mice treated with IL-
1+VEGF as compared to animals treated with IL-1+vehicle (Supplemental Figure 5). Furthermore, 
VEC-Y685F mutant mice that exhibit a defect in vascular permeability induction (9) (Figure 3B and 
C), showed reduced plasma levels of hCXCL8 as compared to levels detected in control VEC-WT 
animals (Figure 5D). The link between vascular permeability induction and tissue to blood chemokine 
movement was further investigated through the use of blocking anti-VE-PTP and anti-VE-cadherin 
antibodies. Specifically, an anti-VE-PTP Ab that inhibits vascular permeability induction through 
activation of Tie-2 (20, 21), (i) significantly suppressed histamine-induced vascular leakage in the 
mouse cremaster muscle (Supplemental Figure 6A), and, (ii) significantly reduced plasma levels of 
locally administered hCXCL8 in mice treated with IL-1+histamine, as compared to control Ab treated-
mice (Figure 5E). Animals treated with the anti-VE-PTP Ab also showed reduced plasma levels of 
endogenously generated CXCL1 as compared to levels detected in control Ab-treated mice 
(Supplemental Figure 6B). In contrast to the inhibitory effects of the anti-VE-PTP Ab, a blocking anti-
VE-cadherin mAb (clone BV13) (22) that promoted vascular leakage induction in the mouse cremaster 
muscle (Supplemental Figure 6C and D), enhanced plasma levels of locally administered hCXCL8 as 
compared to levels detected in control mAb (anti-CD31)-treated mice (Figure 5F).  
Together, through experimental and mathematical modelling, we provide compelling evidence to 
show that the loosening of EC junctions during increased vascular permeability can promote the 
mobilisation of small MW proteins from the interstitial tissue to the blood stream and thus influence 
the compartmentalisation of extravascular chemokines.  
 
Luminal CXCL1 promotes neutrophil reverse TEM  
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We next investigated the functional impact of increased plasma CXCL1 on neutrophil TEM. For this 
purpose, 2h post stimulation of cremaster muscles with IL-1, LysM-EGFP-ki mice were injected i.v. 
with a blocking anti-CXCL1 mAb prior to topical application of histamine. Whilst at the dose employed, 
i.v. administration of the anti-CXCL1 mAb had no impact on plasma protein leakage or total neutrophil 
extravasation (Figure 6A and B), this intervention significantly reduced the frequency of neutrophil 
rTEM events (~60% inhibition) as compared to control Ab-injected mice (Figure 6C). Similarly, 
systemic CXCL1 blockade had no impact on total neutrophil extravasation in cremaster muscles 
subjected to IR insult (Figure 6D) but suppressed neutrophil rTEM in this permeability-enhancing 
reaction (~60% inhibition; Figure 6E). Suggesting that luminal CXCL1 can drive neutrophil rTEM, this 
was categorically investigated through i.v. injection of exogenous CXCL1 in LysM-EGFP-ki mice 
stimulated locally with IL-1 (2h). Within this protocol, i.v. CXCL1 promoted a substantial frequency 
of neutrophil rTEM through cremasteric venules (~30%; Figure 6F), whereas as noted previously 
(Figure 1E), local IL-1 on its own did not cause neutrophil rTEM (Figure 6F). Collectively, the present 
results unequivocally demonstrate that vascular CXCL1 can drive neutrophil TEM towards the luminal 
aspect of the endothelium.  
 
Development of a cell labelling strategy for tracking of neutrophil rTEM in vivo 
Aiming to gain insight into the fate, phenotype and pathophysiological relevance of rTEM neutrophils 
stemming from a local hyperpermeability inflammatory site, we established a method for tracking of 
these cells. Previous studies employing zebrafish and murine models of tissue injury have utilised 
genetically encoded photolabelling protocols to track reverse migrating neutrophils from within injured 
interstitial tissues back into the vascular lumen and into distal organs (23-25). However, as the 
neutrophil reverse migration phenomenon noted in the present study is restricted to breaching of the 
endothelium only, photoconverting and photoactivation of neutrophils confined within tight EC 
junctions or the thin sub-EC space (<3m wide) renders such genetic strategies inappropriate for 
exclusive delineation of rTEM cells (e.g. preliminary works with transgenic mice expressing the Kaede 
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photoconvertible fluorescence protein tracked <10 rTEM neutrophils/inflamed tissue; data not shown). 
Hence, as part of the present study we have developed a labelling method that crisply delineates 
neutrophils that reverse migrate within EC junctions and re-enter the vascular lumen (Figure 7A). The 
method takes advantage of the strong affinity of streptavidin for biotin and our observation that locally 
applied streptavidin is retained within the cremaster muscle tissue and does not move into the 
systemic circulation, even under conditions of increased vascular permeability (Supplemental Figure 
7A). Initial experiments applied this labelling method to staining of neutrophils in IL-1-stimulated 
tissues. Briefly, after local application of IL-1 (1.5h), LysM-EGFP-ki mice were injected i.v. with 
biotinylated anti-Ly6G mAb, a step that as anticipated selectively labelled >99% of all circulating 
neutrophils (Supplemental Figure 7B). Thirty minutes later, cremaster muscles were surgically 
exteriorised and tissues were topically superfused with AF647-streptavidin. Analysis of tissues by 
confocal microscopy showed that with this protocol luminal neutrophils were GFP+ but streptavidin-, 
whilst neutrophils in the sub-EC space and in the interstitial tissue were clearly positive for both GFP 
and streptavidin (Figure 7B). We next sought to investigate the ability of this labelling method to track 
rTEM neutrophils during the hyperpermeability IL-1+histamine reaction where histamine and AF647-
streptavidin were simultaneously superfused onto surgically exteriorised tissues. Here, intriguingly we 
noted that in neutrophils exhibiting TEM, leading protrusions in the sub-EC space rapidly became 
intensely streptavidin+ (Figure 7C), resulting in effective labelling of all neutrophils that partially or fully 
breached the endothelium. This included cells that completely breached the venular wall and entered 
the surrounding interstitial tissue as well as cells that reverse migrated from within EC junctions or the 
sub-EC space back into the vascular lumen (Figure 7A-D). Similar results were obtained when AF647-
streptavidin was injected locally into cremaster muscles (400ng for 2h) as opposed to being topically 
superfused (Supplemental Figure 7C and D). Of importance, unlabelled mice and mice subjected to 
the biotin-streptavidin labelling strategy exhibited similar levels of neutrophil migration into tissues and 
neutrophil rTEM (Supplemental Figure 8A and B as compared to Figures 2A and D) as well as similar 
neutrophil migration velocity within EC junctions and the interstitial tissue (Supplemental Figure 8C 
and D). 
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Thus, we have established a cell labelling technique for direct tracking of neutrophils that exhibit 
reverse TEM in vivo. This methodological advancement enables definitive explorations into the 
phenotype and fate of rTEM neutrophils.     
 
Reverse TEM neutrophils disseminate into the systemic and pulmonary circulation and exhibit 
an activated phenotype 
Exploiting our labelling method, we next investigated the distribution of rTEM neutrophils stemming 
from local hyperpermeability sites. Since our confocal IVM studies showed rTEM neutrophils to re-
enter the vascular lumen and rapidly detach from the luminal aspect of the endothelium (Supplemental 
Video 6), we initially sought to detect these cells in the systemic circulation. For this purpose, using 
mice subjected to cremasteric stimulation with IL-1, blood samples were taken two hours post local 
administration of histamine or vehicle in conjunction with the new biotin-streptavidin labelling protocol. 
Flow cytometry analysis of samples from IL-1-treated mice showed very low levels of streptavidin+ 
circulating blood neutrophils (~0.1%, corresponding to a total of ~800 streptavidin+ neutrophils/ml of 
blood); this number was significantly increased in blood samples of mice locally stimulated with IL-
1+histamine (~0.4%, corresponding to ~2,800 streptavidin+ neutrophils/ml of blood) (Figure 8A and 
B). Aligned with the substantive frequency of neutrophil rTEM seen in the corresponding reactions 
(see Figure 2D), these results strongly indicated the presence of rTEM neutrophils in the systemic 
circulation. Focussing on the hyperpermeability reaction to IL-1+histamine, we next explored the 
phenotype of streptavidin+ neutrophils as compared to streptavidin- cells. Streptavidin+ blood 
neutrophils exhibited no significant change in expressions of L-selectin (CD62L), 1 integrins, ICAM-
2, neutrophil elastase (NE) or CXCR4 but showed significantly increased expression of CD11b, and 
a low but significant increase in expression of ICAM-1 (Supplemental Figure 9A and Figure 8C). 
Based on such an activated phenotype, and as guided by our previous works (14, 15), we 
hypothesised that streptavidin+ rTEM neutrophils may be additionally retained within the pulmonary 
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vasculature. To address this possibility, we analysed the percentage and phenotype of streptavidin+ 
neutrophils in pulmonary vasculature washouts of mice subjected to local cremaster muscle 
stimulations with PBS, histamine, IL-1 or IL-1+histamine (2h) and biotin-streptavidin labelling. 
Whilst animals treated locally with PBS, histamine or IL-1 showed similar levels of streptavidin+ 
neutrophils (~0.2%), mice stimulated with IL-1followed by histamine for 2h showed an enrichment 
of streptavidin+ neutrophils in the pulmonary vasculature (~0.8%) (Figure 8D and E). Increasing the 
local stimulation period with histamine to 4h resulted in a similar level of streptavidin+ neutrophils in 
blood (~0.42%) but led to a reduced and non-significant level in the pulmonary vasculature (~0.2%) 
(Supplemental Figure 9B and C). Interestingly, in mice treated locally with IL-1 followed by 4h 
stimulation with histamine, but not 2h, a significant level of streptavidin+ neutrophils was detected in 
the bone marrow (Supplemental Figure 9D, E, F and G). Together these results suggest that the 
retaining of rTEM neutrophils in the lungs is transient and that this subset of cells eventually migrate 
to the bone marrow. Furthermore, as compared to streptavidin- cells, streptavidin+ pulmonary vascular 
neutrophils showed no significant change in expressions of L-selectin and ICAM-2 but exhibited a 
significant increase in expressions of 1 integrins, CD11b, ICAM-1, NE and CXCR4 (Figure 8F and 
G). The latter is in line with the observed trafficking of the streptavidin+ cells to the bone marrow. Of 
note, in IL-1+histamine-treated mice subjected to our labelling protocol, streptavidin- neutrophils in 
both blood and pulmonary vascular washout samples showed a similar phenotype to neutrophils 
acquired from un-labelled mice treated locally with just PBS, histamine or IL-1 alone (Supplemental 
Figure 10A and B). This crucial set of data precludes the possibility that in IL-1+histamine-treated 
mice circulating soluble factors determine the phenotype of the streptavidin+ cells. Additionally, these 
results suggest that the streptavidin+ rTEM neutrophils have no impact on the phenotype of 
streptavidin- neutrophils.  
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Together, we provide evidence for the ability of rTEM neutrophils stemming from a local 
hyperpermeability site to re-enter the systemic circulation and to traffic to lungs, where they exhibit 
an activated pro-adhesive phenotype, before returning to the bone marrow. 
 
Disseminated rTEM neutrophils localise to sites of vascular leakage in lungs 
We have previously shown an association between rTEM neutrophils stemming from local 
inflammatory sites characterised by reduced junctional expression of EC JAM-C and remote organ 
injury (14, 15). We therefore hypothesised that neutrophil rTEM driven by local hyperpermeability 
could similarly cause distant organ damage. To investigate this notion, pulmonary vascular leakage 
resulting from stimulation of cremaster muscles was assessed by measuring sub-EC and 
extravascular accumulation of intravenously administered fluorescent microspheres (26). 
Furthermore, to investigate if this response was associated with accumulation of rTEM neutrophils 
stemming from the cremaster muscle, the experiments incorporated the new biotin-streptavidin 
labelling protocol. Our findings showed that mice subjected to cremaster muscle stimulation with IL-
1histamine, but neither stimulus on its own or local PBS, exhibited lung vascular leakage (Figure 
9A and B). In addition, whilst all reactions tested exhibited similar levels of total neutrophil recruitment 
to lungs (~15 neutrophils/field of view), a significantly elevated number of streptavidin+ neutrophils 
was detected in lungs of mice subjected to cremaster muscle local hyperpermeability (Figure 9C). 
Furthermore, these studies indicated a significant association between numbers of streptavidin+ 
neutrophils and the extent of increased lung vascular permeability (Figure 9D) and a significant 
association between the presence of streptavidin+ neutrophils and sites of pulmonary vascular 
leakage (Figure 9E and F). Collectively, the findings demonstrate that a local hyperpermeability 
reaction can promote distal organ injury by recruitment of rTEM neutrophils (Figure 10).  
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DISCUSSION 
Enhanced microvascular leakage and neutrophil trafficking are pivotal features of an acute 
inflammatory response. Importantly, the molecular basis of these events are distinct (9) and there is 
ample evidence to show that neutrophil extravasation in vivo per se is not sufficient for increased 
microvascular leakage (present study and (10, 11)). None-the-less, neutrophils, most notably when 
stimulated to adhere by certain chemoattractant mediators (27, 28), can secrete a range of pro-
permeability factors (e.g. VEGF, LTA4, HBP, TNF) (12, 13, 29-31). Here we report for the first time 
that increased vascular permeability can also impact neutrophil trafficking by reversing the directional 
luminal-to-abluminal migration of neutrophils through the endothelium. Mechanistically, this was 
governed by disrupted localisation of tissue chemokines as induced by the movement of chemokines 
into the vascular lumen through leaky venular walls. Crucially, we demonstrate that neutrophils 
stemming from hyperpermeability sites re-enter the systemic circulation, exhibit an activated 
phenotype and traffic to the lungs where they are present at sites of vascular injury. Collectively, 
through identifying a previously unreported link between two fundamental components of 
inflammation, our findings extend current understanding of pathological inflammation and suggest 
that targeting local microvascular permeability may provide an effective means of suppressing 
neutrophil-mediated remote organ damage.  
Intrigued by the lack of investigations into the potential impact of increased vascular permeability on 
neutrophil trafficking, we applied high resolution confocal IVM for simultaneous analysis of these 
phenomena. Our findings revealed that induction of vascular leakage does not grossly alter total 
tissue infiltration of neutrophils over several hours. However, unexpectedly, augmented vascular 
leakage rapidly promotes a significant frequency of neutrophils that have initiated TEM to exhibit 
retrograde motility within EC junctions and eventually re-enter the blood circulation. Increased 
microvascular permeability consistently preceded the occurrence of this aberrant TEM response, 
suggesting a causal link. Direct evidence for this notion was acquired through the use of knock-in 
mice expressing a Y685F mutant of VE-cadherin with selective impaired vascular permeability 
induction (9) that showed reduced disrupted neutrophil TEM. Neutrophil reverse migration within EC 
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junctions, termed “reverse TEM”, has previously been described by our group in relation to multiple 
inflammatory scenarios in the murine microcirculation (6, 14, 15). This response, which was first 
described in vitro for human neutrophils (32) is, however, one of a number of neutrophil reverse 
migration modes that to date have been reported in numerous contexts, experimental models and 
inflammatory conditions (23-25, 33-35). The wide-ranging profiles and potential implications of 
neutrophil retrograde migration begs the need for further explorations of this enigmatic response in 
terms of its mechanisms and consequences.   
In addressing the mechanisms that drive neutrophil rTEM, our previous works identified neutrophil 
elastase-mediated cleavage of EC junctional JAM-C as a trigger of this cellular response (14, 15). 
Together with in vitro studies of monocyte TEM (36), these findings indicated a need for EC JAM-C 
as a regulator of one-way leukocyte trafficking through EC junctions, though the precise molecular 
basis of JAM-C-mediated luminal-to-abluminal neutrophil motility remains unclear. Of note however, 
directly-acting vascular permeability enhancing agents (histamine and VEGF) that effectively 
instigated neutrophil rTEM in IL-1-stimulated tissues, had no impact on JAM-C expression. As an 
alternative mechanism, and based on recent findings showing the significance of compartmentalised 
directional cues in promoting neutrophil diapedesis (6), we hypothesised that increased vascular 
permeability may disrupt the correct positioning of chemotactic signals within the venular wall niche. 
Focussing on CXCL1, a potent neutrophil chemoattractant abundantly generated within our acute 
inflammatory models, elevated plasma levels of this chemokine were noted in all hyperpermeability 
reactions tested. Intriguingly, these results suggested that vascular leakage can prompt the diffusion 
of endogenously generated CXCL1 from the tissue and/or the venular wall into the vascular lumen. 
Support for this notion was acquired through tracking of topically applied 10kDa dextran in histamine-
stimulated tissues by confocal IVM and such an event was predicted by mathematical modelling. 
Briefly, whilst under normal homeostatic conditions, intact EC contacts provide a significant barrier to 
movement of molecules into tissues, this situation changes in inflammation. When vascular 
permeability is increased, EC junctional contacts loosen and although this supports increased 
hydraulic flux, it also causes a decrease in hydraulic velocity. Such a scenario can facilitate diffusion 
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of a small molecule (e.g. a chemokine) from the tissue back into the blood stream as shown here both 
experimentally and mathematically. This hypothesis was conclusively validated through assessing 
the interstitial to vascular lumen distribution of exogenous hCXCL8 following specific genetic or 
pharmacological modulations of vascular permeability induction. Collectively, the findings reveal that 
hyperpermeability inflammatory conditions can promote reverse diffusion of chemokines from the 
tissue to the vascular lumen, a phenomenon that can disrupt the directional motility of neutrophils 
through EC junctions. The latter was definitively illustrated in experiments where systemic blockade 
of CXCL1 prevented neutrophil rTEM in hyperpermeability reactions, and conversely, intravenous 
exogenous CXCL1 promoted neutrophil rTEM.  
The sequence of molecular and cellular events that guide neutrophils from the vascular lumen to the 
interstitial tissue is well established and described by the leukocyte adhesion cascade (3). Here, it is 
considered that chemokines immobilised on the luminal aspect of blood vessels trigger the local arrest 
of neutrophils (3) with sequential, compartmentalised and locally presented chemotactic cues within 
venular walls promoting luminal-to-abluminal diapedesis (6). Whilst glycosaminoglycans (GAGs) are 
considered to provide the principal mode of retaining chemokines on the luminal aspect of blood 
vessels, the retention of chemokines within EC junctions is likely mediated by binding to the atypical 
chemokine receptor ACKR1 that is enriched at these sites (6, 37). Together, due to their pivotal role 
in localisation, retention and/or transport of chemokines, ACKR1 and GAGs are key molecular players 
in supporting leukocyte trafficking (38, 39). In contrast to these physiological regulatory modes, 
increased vascular permeability appears to account for excessive EC junctional motility and resultant 
entry of chemokines into the blood stream. As such, local hyperpermeability disrupts the correct 
spatiotemporal presentation of chemotactic cues within venular walls, and in doing so, disrupts a 
phenomenon that is critical for efficient and unidirectional luminal-to-abluminal migration of 
neutrophils (6).  
Although migration away from sites of inflammation and injury is now an established neutrophil 
behaviour (34), it is highly plausible that the implications of this response are different in diverse 
contexts and in varied experimental models. Most notably, neutrophil retrograde motility within 
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interstitial tissues away from sites of sterile injury, and in some cases re-entry into the blood 
circulation, is proposed as a component of inflammation resolution (24, 33, 40, 41). For example, 
Wang and colleagues reported that neutrophils recruited to a murine thermal hepatic injury model 
contributed to revascularisation of injured tissues and subsequently left the injured site by re-entering 
the local vasculature (24). Using an elegant mouse model that selectively expressed a 
photoactivatable GFP in neutrophils, the authors could track ~10% of the tissue infiltrated neutrophils, 
a procedure that enabled a small number of cells to be tracked to the lungs and a higher number to 
the bone marrow. Phenotypic analysis of photoactivated neutrophils in these organs indicated 
increased expression of CXCR4. Based on the latter, it was concluded that neutrophil migration away 
from injured tissues is a physiological process that may regulate deactivation and/or reprogramming 
of neutrophils in the lungs before they are recruited to the bone marrow via CXCR4 for eventual 
clearance by apoptosis (24). The neutrophil reverse motility response reported in our study is distinctly 
different from that analysed by Wang and colleagues in that it is restricted to EC junctions and the 
sub-EC space and collectively describes the re-entry of transmigrating neutrophils back into the 
vascular compartment prior to the cells fully exiting the venular wall. Whilst we have previously 
associated this response with remote organ damage (14, 15), our earlier works did not provide direct 
evidence for rTEM neutrophils trafficking to secondary organs. To address this vital point, here we 
have developed an in vivo cell-labelling method that precisely and efficiently distinguishes luminal 
neutrophils from all cells that breach EC junctions and hence tags all TEM and rTEM neutrophils 
stemming from the tissue under investigation. As such, a notable strength of our method is that it 
enables analysis of the full sub-population of rTEM neutrophils migrating away from an inflammatory 
site in terms of their fate, phenotype and pathophysiological relevance.   
The application of our tracking method indicated dissemination of labelled rTEM neutrophils from a 
local hyperpermeability site to the systemic circulation where they showed an activated phenotype 
(increased CD11b and ICAM-1). In the same animals, labelled rTEM neutrophils were detected at 
significantly elevated levels in the pulmonary vasculature with an even greater activation state, 
exhibiting further increased expressions of CD11b and ICAM-1, as well as 1 integrins and NE. The 
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latter is highly indicative of degranulation contributing to some of the noted rTEM neutrophil phenotype 
and indeed neutrophils are known to express preformed stores of 2 and 1 integrins that can be 
mobilised to the cell surface during TEM (42). Certainly, there is ample evidence showing that 
engagement of neutrophils with EC junctional molecules can trigger signalling and transcriptional 
events within migrating leukocytes (42), suggesting that rTEM and tissue infiltrated neutrophils may 
exhibit similar phenotypes. In line with this notion, whilst increased expression of ICAM-1 on 
neutrophils is a slow and transcriptionally regulated process (43), both tissue infiltrated and rTEM 
neutrophils can exhibit an ICAM-1hi phenotype (14, 32, 43). Of importance however, although 
increased expressions of integrins, other granular proteins and ICAM-1 on tissue infiltrated 
neutrophils collectively support effective breaching of venular walls, interstitial tissue migration and 
pathogen clearance (42-46), such a phenotype on neutrophils that re-enter the blood circulation could 
be highly detrimental to the host.  In line with this notion, we detected a direct association between 
labelled rTEM neutrophils and lung injury, results that support the paradigm that rTEM neutrophils are 
a sub-set of activated neutrophils that can contribute to turning a local inflammatory response into a 
systemic phenomenon. The precise mechanism through which rTEM neutrophils exert tissue damage 
remains to be elucidated. However, the strong association of NE with the pathogenesis of numerous 
acute and chronic lung disorders (47) suggest increased expression of this serine protease on rTEM 
neutrophils could be a significant factor. Furthermore, elevated expression of integrins, together with 
the ICAM-1hi phenotype, may support increased aggregation and activation of rTEM neutrophils (e.g. 
degranulation and ROS generation) within small blood vessels of remote organs. Of direct relevance 
to this notion, we have previously shown that neutrophil ICAM-1 expression correlates with increased 
ROS generation (43). Additionally, pulmonary vasculature (but not blood) rTEM neutrophils showed 
increased expression of CXCR4, and rTEM neutrophils could be detected in the bone marrow four 
hours post their induction. These results collectively support the belief that neutrophils are retained 
within the lung vasculature in a transient manner during which they may be reprogrammed for homing 
to the bone marrow (24). The difference between our findings and those of other groups in terms of 
linking neutrophil rTEM to distant organ damage could lie in the nature of the reactions investigated, 
the type of retrograde migration being analysed and phenotype of the neutrophils stemming from the 
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primary inflammatory site. Significant to our findings, acute lung injury is a life-threatening 
consequence of numerous local hyperpermeability-inducing conditions such as trauma, and 
pathologies induced by IR injury (48, 49). Thus, we propose that activated rTEM neutrophils stemming 
from local hyperpermeability inflammatory sites could provide a detrimental “cellular” link between 
primary and secondary sites of pathological inflammation.   
In summary, the present results offer a causal link between increased local microvascular leakage 
and neutrophil rTEM, an axis associated with development of remote organ damage. Fundamental to 
this cascade of events is the discovery that increased vascular leakage can induce rapid translocation 
of chemokines from the interstitium into the systemic circulation against hydraulic flow, resulting in 
disrupted directional gradient across the venular wall. This response in turn drives the re-entry of an 
activated sub-set of neutrophils back into the vascular lumen that can then contribute to development 
of lung injury. Collectively, our findings suggest that targeting excessive local microvascular 
permeability maybe a plausible therapeutic strategy for protecting the host from secondary organ 
damage. Furthermore, our results could have implications for tumour cell intravasation and 
dissemination from primary sites of tumour growth that are characterised by leakiness of their blood 
vessels.  
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METHODS 
Antibodies  
The following were obtained commercially: Anti-CD31 (390), PE-anti-CXCR4 (2B11), anti-VE-
cadherin (BV13), control anti-rabbit, anti-VE-cadherin (eBioBV14) mAbs from ThermoFisher 
(Waltham, USA); PB-anti-Gr-1 (RB6-8C5), BV605-anti-CD62L (MEL-14), BV711-anti-CD11b 
(M1/70), AF488-anti-CD115 (AFS98), AF488-anti-CD102 (3C4 MIC2/4), PE/Dazzle594-anti-CD54 
(YN1/1.7.4), PE/Cy7-anti-CD29 (HM1-1), APC-Cy7-anti-CD115 (AFS98), Biotin-anti-Ly-6G (1A8) 
mAbs from Biolegend (Cambridge, UK); Blocking anti-CXCL1 (48415) from R&D Systems (Abingdon, 
UK); Rabbit anti-human CXCL8 (NBP2-33819) from NOVUS (Abingdon, UK); Anti-NE (ab68672) from 
Abcam (Cambridge, UK); Anti-SMA (1A4), anti-CD31 (2H8) from Sigma-Aldrich (Poole, UK). Rabbit 
polyclonal anti-VE-PTP was generated as described (50). The following were gifts: Rabbit polyclonal 
anti-JAM-C (clone H33; Dr Michel Aurrand-Lions, INSERM, CRCM, France) and anti-MRP14 mAb 
(Dr Nancy Hogg, The Francis Crick Institute, UK).  
 
Animals 
Male WT C57BL/6 (Charles River, UK) and LysM-EGFP-ki (51) mice (8-12 weeks old) were used for 
all studies. VEC-Y685F-ki mutant mice that exhibit a single point mutation in VE-Cadherin were 
generated as previously described (9).  
 
Generation of chimeric mice 
VEC-WT and VEC-Y685F mice were lethally irradiated with 1 dose of 9 Gy over a time period of 
11min and were subsequently injected i.v. with 1.5-3x106 bone marrow cells from LysM-EGFP-ki 
mice. Level of engraftment was evaluated 4 weeks after reconstitution and all mice showed more 
>99% of GFP+ neutrophils with similar neutrophil counts.  
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Confocal IVM of the mouse cremaster muscle 
Anaesthetised (isofluorane, 3%) male mice received an intrascrotal (i.s.) injection of fluorescently-
labelled anti-CD31 mAb (4g) and/or IL-1 (50ng, R&D Systems, UK), LTB4 (300ng, Cambridge 
Bioscience, UK) to label vessels within the tissue and/or induce an inflammatory response, 
respectively. Control animals received PBS. The cremaster muscles were then prepared for intravital 
imaging 2h or 30min post IL-1 or LTB4 administrations, respectively, as described (14, 15). Topical 
application of histamine (30M, Sigma-Aldrich) onto exteriorised tissues, or intravenous (i.v.) injection 
of VEGF (4g/mouse, R&D Systems) was used to induce vascular leakage. Ischemia-reperfusion (IR) 
injury was induced as described (14, 15). In some experiments, anti-CXCL1 mAb or control IgG2a 
(1mg/kg) and anti-VE-PTP Ab (100-200g) or rabbit IgG control (200g) were injected i.v. as indicated 
in relevant texts. In some works, recombinant mCXCL1 (50ng, Peprotech, UK) was injected i.v. 2h 
post IL-1. To visualize vascular leakage, 75kDa-TRITC-dextran (40mg/kg, Sigma-Aldrich) was 
injected i.v. (via tail vein cannula) 1min prior to the superfusion of histamine, in combination with i.v. 
injection of VEGF or during the reperfusion phase of IR-stimulated tissues. In some experiments, 
10kDa-AF488-dextran (10g/ml, ThermoFisher) was superfused 2min after i.v. injection of 75kDa-
TRITC-dextran for 10min. The superfusate was then replaced by either Tyrode’s solution containing 
histamine (30M) or vehicle control for an additional 30min. To label rTEM neutrophils, biotinylated-
anti-Ly6G mAb (2g) was injected i.v. 1.5h after IL-1 stimulation of tissues. Following exteriorisation, 
the cremaster muscle was superfused with AF647-streptavidin (1g/ml, ThermoFisher) with Tyrode’s 
solution with or without histamine (30M). Z-stack images of post-capillary venules (20-40m in 
diameter) were captured using Leica SP5 or SP8 confocal microscopes incorporating a x20 water-
dipping objective (NA 1.0), as detailed (6, 14).  
 
Quantification of neutrophil TEM, microvascular leakage and streptavidin labelling  
Still images and 4D live recordings were analysed using IMARIS software™ (Bitplane, Zurich, 
Switzerland). Extravascular neutrophils were defined as those that had fully transmigrated and 
passed through the pericyte layer, recognisable via a change in their morphology and expressed as 
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number of cells/mm3 of tissue. Reverse TEM neutrophils were defined as cells that moved in an 
abluminal-to-luminal direction within EC junctions. Normal neutrophil TEM was classified as a 
response in which the cells migrated through EC junctions only in a luminal-to-abluminal direction, as 
previously described (14, 15). Extravascular leakage was quantified by interstitial accumulation of i.v. 
75kDa-TRITC-dextran and presented as MFI of indicated time-points, measuring 6-8 regions of 
interest (ROI) in the interstitium (excluding areas exhibiting dextran-positive perivascular cells) and 
30m away from the vessel wall. These readings were then normalised in relation to the first two MFI 
readings obtained post i.v. injection of the tracer and presented as normalised MFI. Similar analysis 
was conducted for the quantification of tissue levels of 10kDa-AF488-dextran (MFI normalised to the 
first two readings post superfusion of the tracer). Interstitial neutrophil speed and fluorescence 
intensity of AF647-streptavidin were analysed using the spot or iso-surface functions of IMARIS 
software, respectively.      
   
Bright-field IVM of the mouse cremaster muscle 
Mice were injected i.s. with IL-150ng) or PBS alone for 2h prior to cremaster muscle exteriorisation 
and prior to the superfusion of histamine (30M) or vehicle, as described above. Leukocyte rolling, 
firm arrest and extravasation within 20-40m post-capillary venules were quantified by IVM over a 
1.5h period using a bright-light microscope (Axioskop FS, Carl Zeiss, UK), as detailed (44). Several 
vessel segments (3-5) from multiple vessels (3-5) were quantified for each animal.  
 
Quantification of chemokine and dextran levels in tissue and plasma 
Anaesthetised (isofluorane 3%) mice were subjected to cremasteric ischemia (40min) or injected i.s. 
with IL-1 (50ng) or TNF (300ng R&D Systems, Abingdon, UK) in 200l PBS. Control animals 
received PBS only. Two hours later, animals were injected with i.s. histamine (30M solution) or PBS 
(both in 200l) or i.v. VEGF (4g/mouse) or PBS. Cremaster muscles and plasma samples (in 50mM 
of EDTA) were harvested 30min later. In some experiments hCXCL8 (500ng, Peprotech) was co-
injected with IL-1 (50ng) for 1h prior to the end of the in vivo test period (i.e. 2.5h). In some 
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experiments, mice were treated i.v. with a blocking anti-VE-PTP Ab (200g) (20, 21) or rabbit IgG 
control (200g) 30min after hCXCL8 and IL-1 injection. Other experiments involved treating the mice 
with a blocking anti-VE-cadherin mAb (BV13; 100g) (22) or a control mAb (anti-CD31 mAb, clone 
390; 100g) i.s. for 3h followed by local injection of hCXCL8 for 1h prior to tissue and plasma 
collection. Tissues were homogenised in PBS containing 0.1% Triton X-100 and 1% Halt Protease 
and Phosphatase Inhibitor cocktail (ThermoFisher) and mechanically dissociated using the 
Precellys24 beat-beading system (Bertin Technologies, France). Levels of mCXCL1 and hCXCL8 
were analysed as per the manufacturer’s instructions by ELISA (R&D Systems and ThermoFisher, 
respectively, sensitivity: 2pg/ml). The quantity of chemokine detected in tissues was normalised to 
protein content as determined using a BCA assay (Thermo Fisher). Levels of 10kDa-AF488-dextran 
in plasma was quantified using a NOVOstar (0700) microplate reader. 
 
Immunofluorescence staining and confocal analysis of tissues 
Whole-mount cremaster muscles were analysed for expressions of hCXCL8, JAM-C, red-(580/605)-
microbeads (20nm in diameter, 9.1x1013 beads; ThermoFisher Waltham, MA, USA), and AF647-
streptavidin as previously published (6, 15). Briefly, surgically removed tissues were fixed in ice-cold 
PFA (4% in PBS) for 45min, blocked and permeabilised at room temperature for 4h in PBS containing 
25% FCS and 0.5% Triton X-100, and incubated overnight (anti-hCXCL8, anti-MRP14, anti--SMA, 
anti-CD31 staining) or 72h (anti-JAM-C staining) at 4°C with primary antibodies. Immunostained 
tissues were imaged with an inverted Zeiss 800 confocal laser-scanning microscope. JAM-C 
expression within the VE-cadherin channel was quantified as previously described (14, 15). For 
analysis of hCXCL8 localisation, ECs, neutrophils and pericyte isosurfaces were created based on 
regions immunostained for CD31 (CD31high junctional and CD31dim non-junctional regions), MRP14 
and -SMA, respectively. EC body and junctional hCXCL8 expressions were quantified as MFI within 
these isosurfaced regions. The MFI of fluorescent beads present in the sub-endothelial space (<1m 
from ECs) was quantified as a measure of cremaster muscle vascular leakage. An isosurface using 
the CD31 channel was generated to exclude fluorescent signal of beads inside the vascular lumen. 
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All protein expression levels were quantified from 6-12 images/tissue and expressed as MFI values 
of tissues stained with specific antibodies post subtraction of MFI values acquired from tissues stained 
with isotype control antibodies. 
 
Analysis of blood, pulmonary vascular washout and bone marrow neutrophils by flow 
cytometry 
Mice received an i.v injection of biotin-anti-Ly6G mAb (2g) 90min post stimulation of cremaster 
muscles with locally administered IL-1(50ng) or PBS. Mice were locally injected 30min later with 
histamine (200l of 30M solution) or PBS in combination with AF647-streptavidin (400ng). Whole 
blood and lung vascular washout were collected 120-240min later as previously described (14, 15), a 
method that recovered ~50% of the lung pulmonary vascular neutrophils. Bone marrow was isolated 
from 1 femur/animal. The samples were then analysed using an LSR Fortessa flow cytometer (Becton 
Dickinson) and FlowJo software (TreeStar). Following doublets exclusion, neutrophils from LysM-
EGFP-ki and WT mice were gated as LysM-EGFPhigh/GR-1high or GR-1high/CD115-, respectively. 
Leukocyte numbers were determined using fluorescent counting beads. 
 
Analysis of lung vascular leakage 
Pulmonary vascular leakage was quantified by adapting published methods (26). Briefly, mice were 
injected i.v. with crimson-(625/645)-microbeads (20nm in diameter, 9.1x1013 beads;ThermoFisher), 
biotin-anti-Ly6G (2g) and AF555-anti-CD31 mAb (10g) in 150l sterile PBS, 90min post-IL-1-
stimulation of cremaster muscles (50ng in 200L of PBS). Thirty minutes later, mice were injected i.s. 
with histamine (200l of 30M solution) or PBS in combination with Atto425-streptavidin (400ng, 
Sigma-Aldrich, Poole, UK) for 120min. At the end of the reaction, mice were sacrificed, the descending 
vena cava was clamped and ice-cold PFA (2% in PBS) was perfused via the right ventricle. Lung 
lobes were excised and placed on top of a cover slip and were imaged immediately in situ with an 
inverted Zeiss 800 confocal laser scanning microscope. The MFI of fluorescent beads present in the 
extravascular space (from 5-7 images/tissue from different lung lobes) was quantified as a measure 
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of lung vascular leakage. For this purpose, an isosurface was generated using the anti-CD31 mAb to 
exclude fluorescent signal of beads inside the vascular lumen. To quantitatively analyse the 
association between strept+ neutrophils and regions of vascular leakage, we arbitrarily defined strept+ 
neutrophil regions as areas that expressed at least one strept+ neutrophil within a perimeter of 60m. 
Control areas within the same image were defined as similar size regions that were devoid of strept+ 
neutrophils. 
 
Statistical analysis 
Data analysis was performed using GraphPad Prism 6 (GraphPad software). Results are expressed 
as mean±SEM and the n numbers for each dataset is provided in the figure legends. Statistical 
significance was assessed by 2 tailed Student’s t test, one-way or two-way ANOVA followed by 
Bonferroni’s post-hoc test. A P value less than 0.05 was considered significant. 
 
Study approval 
All in vivo experiments were conducted under the UK legislation according to the Animal Scientific 
Procedures Act 1986, with all procedures being conducted in accordance with UK Home Office 
regulations.  
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FIGURES AND FIGURES LEGENDS 
Figure 1. Hyperpermeability inflammatory reactions are associated with neutrophil reverse 
transendothelial migration. Cremaster muscles of LysM-EGFP-ki mice were subjected to IL-1- or 
LTB4-induced inflammation (120 and 30min, respectively), or to IR injury (40min ischemia + 1-2h 
reperfusion) and analysed by confocal IVM. PBS or sham-operated animals were used as control. 
AF647-labelled anti-CD31 mAb was injected i.s. to visualise EC junctions (red) and i.v. fluorescent 
(75kDa) TRITC-dextran was used to visualise vascular leakage (blue pseudocolor intensity). (A) 
Representative images of IR-stimulated cremasteric venules (see Supplemental movie 1), showing 
the development of an inflammatory response in terms of neutrophil migration (green GFPbright 
neutrophils; top panels) and dextran leakage (blue; bottom panels) at the indicated times post 
reperfusion. Scale bars, 20m. (B) Total neutrophil extravasation (n=5-12 mice/group). (C) Time-
course of dextran accumulation in the perivascular region of a selected post-capillary venule (n=3-10 
mice/group). (D) Representative images of an IR-stimulated cremasteric post-capillary venule at 
different times post reperfusion (see Supplemental movies 2 and 3) illustrating a normal neutrophil 
TEM (top panels) and a reverse TEM (bottom panels) event. Luminal and cross-sectional views with 
arrows indicating the direction of motility of the indicated neutrophil. Scale bars, 5m. (E) Frequency 
of neutrophil reverse TEM events in relation to total TEM events of 20.7±2.1 (IL-1), 31.3±5.9 (LTB4) 
and 15±2.4 (IR injury) per 300m venular segments within 2h microscopy periods (mean±SEM, n=6-
9 mice/group). (F) Temporal association of dextran leakage and cumulative frequency of neutrophil 
reverse TEM (n=4 mice). Data are mean±SEM (each dot represents one mouse/independent 
experiment). Statistically significant differences from PBS (B) or IL-1 (E)-treated mice are indicated 
by **p<0.01,***p<0.001, one-way ANOVA followed by Bonferroni’s post-hoc test. 
 
Figure 2. Induction of microvascular leakage promotes neutrophil reverse transendothelial 
migration. Cremaster muscles of LysM-EGFP-ki mice were subjected to IL-1-induced inflammation 
for 120min and analysed by confocal IVM. AF647-labelled anti-CD31 mAb (i.s.) and 75kDa-TRITC-
dextran (i.v.) were used to visualise EC junctions (red) and vascular leakage (blue pseudocolor 
intensity), respectively. Mice were superfused with histamine (30M) or injected i.v. with VEGF (4g) 
2h post-IL-1 stimulation. (A) Total neutrophil extravasation (n=4-5 mice/group). (B) Representative 
images of a post-capillary venular segment subjected to IL-1+histamine stimulation at different time-
points post application of histamine, illustrating neutrophil TEM and dextran leakage responses (see 
Supplemental movie 4). Scale bars, 20m. (C) Time-course of dextran accumulation in the 
perivascular region of a selected post-capillary venule (n=3-9 mice/group). (D) Frequency of 
neutrophil reverse TEM events in relation to total TEM events of 15.2±2.4 (IL-1), 19.8±2.9 (IL-
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1+Hist) and 21±3.6 (IL-1+VEGF) per 300m venular segments within 2h microscopy periods (mean 
± SEM, n=4-10 mice/group). (E) Temporal association of dextran leakage and cumulative frequency 
of neutrophil reverse TEM (n=7-9 mice/group). Data are represented as mean±SEM (each dot 
represents one mouse/independent experiment). Statistically significant differences from PBS (A) or 
IL-1 (D)-treated mice are indicated by *p<0.05,**p<0.01,***p<0.001, one-way ANOVA followed by 
Bonferroni’s post-hoc test. 
 
Figure 3. Chimeric VEC-Y658F mice exhibit reduced microvascular leakage induction and 
neutrophil reverse TEM. (A) Generation of chimeric mice exhibiting LysM-EGFP-ki haematopoietic 
cells within VEC-WT or VEC-Y658F recipients. (B) Representative confocal IVM images of post-
capillary venular segments (stained with anti-CD31; red) subjected to IL-1+histamine stimulation at 
two time-points post application of histamine in chimeric VEC-WT and VEC-Y658F mice, illustrating 
dextran leakage (blue pseudocolor intensity). Scale bars, 10m. (C) Time-course of dextran 
accumulation in the perivascular region of selected IL-1-stimulated post-capillary venules in VEC-
WT and VEC-Y658F chimeric mice post topical application of histamine (n=6-12 mice per group). (D) 
Total neutrophil extravasation (n=5-11 mice per group). (E) Frequency of neutrophil reverse TEM 
events in relation to total TEM events of 16.6±2.1 (VEC-WT) and 19.2±3.1 (VEC-Y685F) per 300m 
venular segments within 2h microscopy periods (mean ± SEM, n=5-11 mice). Data are represented 
as mean±SEM (each dot represents one mouse/independent experiment). Indicated statistical 
differences are shown by *p<0.05, two-tailed Student’s t-test (ns = not significant). 
 
Figure 4. Stimulated microvascular leakage induces movement of small molecular weight 
proteins into the vascular lumen. (A-D) Cremaster muscles of WT mice were stimulated with IL-1 
or TNF for 2h followed by local injection of histamine or i.v. VEGF (or corresponding vehicle), for 
30min prior to collection of tissue and plasma samples for quantification of CXCL1 levels by ELISA. 
Mice subjected to PBS, histamine or VEGF alone were used as control (n=4-7 mice/group). (E) 
Representative images of selected IL1-stimulated post-capillary venules showing movement of i.v. 
75kDa-TRITC-dextran (marker of vascular leakage; red) and topically applied 10kDa-AF488-dextran 
(superfused for 10min; green) post topical superfusion of PBS vehicle (top panels) or histamine 
(30M, lower panels, see Supplemental movie 5). Dashed lines indicate blood vessel borders, scale 
bars, 20m. (F and G) Time-course of 75kDa-TRITC- and 10kDa-AF488-dextran accumulation in the 
perivascular region of selected IL-1-stimulated post-capillary venules post superfusion of vehicle (F, 
n=3 mice) or histamine (G, n=3 mice). (H) Quantification of 10kDa-AF488-dextran in plasma samples 
of mice treated as detailed above (n=3 mice/group). (I) Schematic diagram illustrating the 
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mathematical calculation of the Péclet number (Pe) (see Supplemental Figure 4). Data are 
represented as mean±SEM (each dot represents one mouse/independent experiment). Statistically 
significant differences from PBS (A-D) or IL1+vehicle (H) are indicated by 
*p<0.05,**p<0.01,***p<0.001, between groups as indicated by lines by #p<0.05, one-way ANOVA 
followed by Bonferroni’s post-hoc test or two-tailed Student’s t-test (ns = not significant).          
 
Figure 5. Vascular leakage induction promotes trafficking of tissue chemokine through 
venular walls. Cremaster muscles were injected locally with IL-1 (50ng) and human CXCL8 
(hCXCL8, 500ng) for 1h, followed by i.s. injection of vehicle (control) or histamine for a further 1h. (A) 
Representative confocal images of post-capillary venules stained for hCXCL8 within an EC (labelled 
by anti-CD31) isosurface mask with an enlarged image of the boxed region. Scale bars, 2m. (B) 
Quantification of hCXCL8 MFI on EC body and junctions (n=8 mice/group). (C-F) Plasma levels of 
locally applied hCXCL8 in WT mice (C), VEC-WT and VEC-Y685F mice (D), in mice treated with a 
control or anti-VE-PTP Ab (200g, i.v.) (E), or treated with an anti-VE-cadherin mAb (i.s. BV13, 
100g), or a control mAb (non-blocking anti-CD31 mAb, 100g) for 3h prior to local administration of 
tissues with hCXCL8 for 1h (n=4-8 mice/group) (F). Data are represented as mean±SEM (each dot 
represents one mouse/independent experiment). Statistically significant differences cell body vehicle 
vs cell body histamine and Jn vehicle vs Jn histamine groups were analysed by one-way ANOVA 
followed by Bonferroni’s post-hoc test (*p<0.05,**p<0.01). Differences between the other indicated 
groups are shown by *p<0.05,**p<0.01,***p<0.001 analysed by two-way ANOVA followed by 
Bonferroni’s post-hoc test or two-tailed paired or unpaired Student’s t-test.  
 
Figure 6. Systemic CXCL1 promotes neutrophil reverse TEM. Cremaster muscles of LysM-EGFP-
ki mice were stimulated with IL-1 (50ng for 2h) followed by topical superfusion of histamine onto 
exteriorised tissues or subjected to IR injury. Blocking anti-CXCL1 mAb (1mg/kg), or control IgG, was 
injected i.v. 30min before exteriorisation of tissues or at the point of tissue reperfusion. (A) Time-
course of dextran accumulation in the perivascular region of selected stimulated post-capillary 
venules. Tissue dextran accumulation is represented as normalised MFI (n=4-6 mice per group). (B) 
Total neutrophil extravasation (n=4-5 mice/group) and (C) frequency of neutrophil reverse TEM 
events in relation to total TEM events of 14±2 (control mAb) and 20±2.9 (anti-CXCL1 mAb) per 300m 
venular segments within 2h microscopy periods (mean ± SEM, (n=5-6 mice/group). (D) Total 
neutrophil extravasation (n=3-6 mice/group) and (E) frequency of neutrophil reverse TEM events in 
relation to total TEM events of 26.7±3.8 (control mAb) and 26±4.3 (anti-CXCL1) per 300m venular 
segments within 2h microscopy periods (mean ± SEM, n=3-7 mice/group). (F) Cremaster muscles of 
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LysM-EGFP-ki mice were stimulated with IL-1 (50ng for 2h) followed by i.v. injection of murine 
rCXCL1 (50ng). Frequency of neutrophil reverse TEM events in relation to total TEM events of 16±2.8 
(IL-1) and 12.9±1.8 (IL-1+CXCL1) per 300m venular segments within 2h microscopy periods 
(mean±SEM, n=5-7 mice/group). Data are represented as mean±SEM (each dot represents one 
mouse/independent experiment). Statistically significant differences from control mAb-treated groups 
(C and E) or IL-1 treated-tissues (F) are shown by *p<0.05,***p<0.001, two-tailed Student’s t-test. 
    
Figure 7. Development of an in vivo labelling strategy for tracking rTEM neutrophils. (A) 
Diagram detailing the labelling method. Cremaster muscles of LysM-EGFP-ki mice were stimulated 
with IL-1 (50ng for 2h) followed by an i.v. injection of biotinylated-anti-Ly6G (2g) to label blood 
neutrophils at t=90min. The tissues were superfused with histamine (30M) or vehicle in conjunction 
with AF647-streptavidin (1g/ml) for 2h. (B) Representative confocal image of an IL-1stimulated 
post-capillary venule illustrating the extent of AF647-Strept labelling of neutrophils at different stages 
of trafficking (left panel). Right panels shown enlarged images of the boxed regions and illustrate 
examples of AF647-Strept- luminal, AF647-Strept+ sub-EC and AF647-Strept+ interstitial neutrophils. 
Scale bars, 5m. (C) Representative confocal IVM images of a tissue stimulated with IL-1+Hist (see 
Supplemental movie 6) illustrating the effective labelling of an rTEM event. The exemplified neutrophil 
shows that once the cell has breached an EC junction, the leading body part in the sub-EC space 
rapidly becomes AF647-Strept+ whilst the luminal body segment remains AF647-Strept-. The AF647-
Strept+ neutrophil can be easily tracked as it migrates in a reverse manner towards the vascular lumen 
and re-enters the blood stream. Luminal and cross-sectional views are shown with the arrows 
indicating the direction of motility of the indicated neutrophil. Scale bars, 3m. (D) Fluorescence 
intensity of AF647-streptavidin on neutrophils in the venular lumen, tissue and cells exhibiting rTEM 
(n=4 mice/group) during an IL-1+histamine reaction. Data are represented as mean±SEM (each dot 
represents one mouse/independent experiment). Statistically significant differences from luminal 
neutrophils is shown by **p<0.01,***p<0.001, one-way ANOVA followed by Bonferroni’s post-hoc test. 
 
Figure 8. Labelled rTEM neutrophils are present in blood and pulmonary vasculature and show 
an activated phenotype. (A and B) LysM-EGFP-ki mice were subjected to local cremaster muscle 
stimulation with IL-1 (2h) and an i.v. injection of biotinylated-anti-Ly6G (2g) at t=90min. The tissues 
were then superfused with histamine (30M) or vehicle in conjunction with AF647-streptavidin 
(1g/ml) for 2h. Peripheral blood was analysed for the frequency of AF647-Strept+ neutrophils. (A) 
Representative flow cytometry profiles and (B) frequency of AF647-Strept+ neutrophils (LysM-
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GFPhigh/Gr-1high) (n=6 mice/group). (C-G) WT mice were subjected to cremaster muscle stimulation 
with IL-1 or PBS for 2h followed by i.v. injection of biotinylated-anti-Ly6G (2g) at t=90min. The mice 
then received an i.s. injection of AF647-Strept (400ng) co-administered with histamine (200l of 30M 
solution) or PBS for 2h. Peripheral blood and pulmonary vascular washout samples were analysed 
by FACS. (C) Expression of indicated markers on AF647-Strept+ neutrophils relative to levels on 
AF647-Strept-  neutrophils in blood samples collected from mice subjected to IL-1+histamine, as 
measured by Geometric MFI (gMFI) (n=5-8 mice/group). (D) Representative flow cytometry profiles 
and (E) frequency of pulmonary vascular washout AF647-Strept+ neutrophils (Gr-1high/CD115-) (n=4-
8 mice/group). (F) Representative FACS histograms and (G) expression of indicated markers on 
AF647-Strept+ neutrophils relative to levels on AF647-Strept- neutrophils in pulmonary vascular 
washout samples collected from mice stimulated with IL-1+histamine, as measured by gMFI (n=6-9 
mice/group). Data are represented as mean±SEM (each dot represents one mouse/independent 
experiment). Statistically significant differences from IL-1 (B), gMFI of indicated markers of blood 
AF647-Strept- neutrophils (C), PBS (E) and gMFI of indicated markers on pulmonary vascular 
washout AF647-Strept- neutrophils (G) are shown by *p<0.05,***p<0.01 or by indicated comparisons 
##p<0.01, two-tailed Student’s t-test or one-way ANOVA followed by Bonferroni’s post-hoc test 
(ns=not significant).  
 
Figure 9. Accumulation of labelled rTEM neutrophils in lungs is linked with lung injury. The 
cremaster muscles of LysM-EGFP-ki mice were locally stimulated with IL-1 or PBS (2h). Mice were 
injected i.v. with AF555-anti-CD31 mAb (10g), biotin-anti-Ly6G mAb and fluorescent microspheres 
(20nm diameter, 9.1x1013 beads) at t=90min to label the vasculature, neutrophils and to quantify 
vascular leakage, respectively. To induce and to track rTEM neutrophils stemming from the cremaster 
muscles, tissues were additionally stimulated with locally applied histamine or vehicle (PBS) in 
combination with Atto425-Streptavidin (AT425-Strept, 400ng) for 120min. The lungs were then 
analysed by confocal microscopy. (A) Representative confocal images of alveolar capillaries in whole-
mount imaged lungs of mice in which the cremaster muscles were locally stimulated as indicated 
(CD31-labelled vessels, red; neutrophils, blue; extravascular beads, green). Scale bars, 20m. (B) 
Lung vascular leakage as quantified by accumulation (MFI) of extravascular beads (n=4-6 
mice/group) and (C) number of AT425-Strept+ neutrophils per field of view (n=4-6 mice per group), in 
mice subjected to indicated cremaster muscle stimulations. (D) Correlation of the number of AT425-
Strept+ neutrophils and extravascular beads in lung tissues (n=4-6 mice/group). Line indicated linear 
regression and dashed lines 95% confidence band (Spearman r=0.7). (E) High magnification images 
of lung sections showing AT425-Strept+ neutrophils in close apposition to sites of extravascular 
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fluorescent bead accumulation. Scale bars, 3m. (F) Lung vascular leakage in close proximity 
(<60m) of AT425-Strept- neutrophils or AT425-Strept+ neutrophils (n=6 mice/group). Data are 
represented as mean±SEM (each dot represents one mouse/independent experiment). Statistically 
significant differences from PBS or indicated group are shown by **p<0.01,***p<0.001, and between 
indicated groups by ##p<0.01,###p<0.01, one-way ANOVA followed by Bonferroni’s post-hoc test or 
paired t-test or Spearman’s rank correlation test (ns=not significant).  
 
Figure 10. Schematic diagram of the cascade of events that link a local hyperpermeability 
inflammatory reaction to neutrophil rTEM and development of lung injury. 
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Supplemental Figure 1. Effect of topical histamine and systemic VEGF on neutrophil-vessel 
wall interactions and microvascular leakage in the cremaster muscle. (A-C) Cremaster muscles 
of WT mice were exteriorised, superfused with either histamine (30 M) or vehicle (PBS) and analysed 
for neutrophil-vessel wall interactions by brightfield IVM. Number of rolling (A, cell number/min, n = 3 
mice per group), adherent (B, n = 3 mice per group) and extravasated (C, n = 3-8 mice per group) 
leukocytes per 100 m length of post-capillary venules. (D) Effect of topical histamine (30 M) on 
leukocyte adhesion in IL-1-stimulated tissues (n = 3-5 mice per group). (E and F) LysM-EGFP-ki 
mice, subjected to an i.s. injection of an anti-CD31 mAb to label endothelial cells junctions, were 
injected with i.s. PBS or IL-1 (50 ng) for 2 h. The mice were then injected i.v. with VEGF (4 g/mouse) 
and 75 kDa-TRITC-dextran and neutrophil responses and vascular leakage were analysed by 
confocal IVM. (E) Time-course of dextran leakage into the perivascular region of a selected post-
capillary venule (n = 3-5 mice per group). (F) Neutrophil extravasation (n = 3-5 mice per group). Data 
are represented as mean ± SEM (each dot represents one mouse and one independent experiment). 
Statistically significant differences from PBS are shown by *p<0.05, **p<0.01 ***p<0.001, two-tailed 
Student’s t-test or one-way ANOVA followed by Bonferroni’s post hoc test (ns = not significant).  
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Supplemental Figure 2. Histamine has no impact on endothelial cell junctional JAM-C 
expression. Cremaster muscles of WT animals were injected with IL-1 or PBS injection (2 h) prior 
to the local administration of histamine or vehicle for 30 mins. Tissues were then collected, 
immunostained for JAM-C and the expression of EC junctional JAM-C was quantified by confocal 
microscopy (n = 3-4 mice per group). Data are represented as mean ± SEM (each dot represents one 
mouse and one independent experiment). No statistical differences were obtained between any of 
the groups and PBS as analysed using one-way ANOVA followed by Bonferroni’s post hoc test.  
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Supplemental Figure 3. Mice subjected to cremasteric IR injury exhibit elevated levels of 
CXCL1 in tissues and plasma. Cremaster muscles of WT animals were subjected to IR injury (40 
min ischemia followed by 30 min reperfusion period). Tissue (A) and plasma (B) were collected and 
analysed for CXCL1 levels by ELISA (n = 6 mice per group). Data are represented as mean ± SEM 
(each dot represents one mouse and one independent experiment). Statistically significant 
differences from PBS are shown by **p<0.01, ***p<0.001, two-tailed Student’s t-test.   
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Supplemental Figure 4. Mathematical modelling of molecular flux across cremasteric venules. 
Estimation of the Péclet number at 5 cm.H2O net pressure difference for 4 kDa dextran, 40 kDa 
dextran, albumin and 10 kDa dextran assuming different distributions of resistance across the vessel 
wall (67% of the resistance across the glycocalyx, 50% across the glycocalyx or 33% across the 
glycocalyx). The hydraulic conductivity is well characterised from published works as detailed below. 
The boxed data indicate the hydraulic conductivity in the cremaster muscle microcirculation under 
homeostatic conditions (0.1-0.3x10-7cm/s.cmH2O) with the arrow indicating changes in hydraulic 
conductivity following hyperpermeability.* Indicates typical value for more permeable vessels (e.g. 
mesenteric capillaries).  
 
Text associated with Supplementary Figure 4 
Molecular flux is determined by a combination of diffusive and advective transport. For a 
macromolecule produced extravascularly to enter the circulation, the diffusive flux from tissue to blood 
must be high enough to overcome the opposing advective flux. This ratio can be defined by the Péclet 
number (Pe): 
𝑃𝑒 =  
𝐴𝑑𝑣𝑒𝑐𝑡𝑖𝑣𝑒 𝑇𝑟𝑎𝑛𝑠𝑝𝑜𝑟𝑡 𝑅𝑎𝑡𝑒
𝐷𝑖𝑓𝑓𝑢𝑠𝑖𝑣𝑒 𝑇𝑟𝑎𝑛𝑠𝑝𝑜𝑟𝑡 𝑅𝑎𝑡𝑒
=
𝑉.𝐿
𝐷
    EQ. 1 
The advective transport rate is the hydraulic velocity (V) and the diffusive transport rate is the diffusion 
coefficient (D) divided by the distance (L), determined in the present study by the endothelial 
intercellular cleft length (1). If the Pe is near to 1 then neither fluxes are dominant; if the Pe is much 
greater than 1 then diffusion cannot effectively oppose filtration and the molecule cannot travel against 
the flow; if Pe is much less than 1, then there can be diffusion against the flow of fluid. Although the 
exact combination and interaction of blood vessel wall molecular and cellular structures on venular 
wall Pe is unknown, particularly during inflammation, a solid understanding of the permeability of the 
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vessel wall as a whole to both macromolecules and to water (hydraulic conductivity) enables 
mathematical modelling of molecular flux across cremasteric venular walls. In normal physiology, in 
continuous vessels such as those in the muscle, the fluid from the pressurised small blood vessel 
(e.g. postcapillary venules) needs to move through the endothelial cell (EC) glycocalyx, funnelled 
through the EC intercellular clefts and then further funnelled through the breaks in junctional strands 
within the EC clefts. In our case equation 1 can be rewritten for a molecule i where 𝐿𝑝is the hydraulic 
conductivity, 𝐿𝑐𝑙𝑒𝑓𝑡  the cleft length, 𝐷𝐶𝑙𝑒𝑓𝑡
𝑖   the diffusion coefficient in the cleft, ∆𝑃 the net change of 
pressure, and 𝐴𝑂𝑝𝑒𝑛 the area of open cleft available to transport per unit area. 
𝑃𝑒𝑖 =  
[
𝐿𝑝
∆𝑃.𝐴𝑂𝑝𝑒𝑛
].𝐿𝑐𝑙𝑒𝑓𝑡
𝐷𝐶𝑙𝑒𝑓𝑡
𝑖       EQ. 2 
Due to the extensive body of research on mesenteric microcirculation permeability the following 
calculations will be based on mesenteric vessels and then adapted for the cremaster blood vessel 
where only Lp has been measured. 
For every 1 µm2 of blood vessel surface area there are 0.1 µm of EC intercellular cleft with 
approximately 0.01 µm of EC open junction for rat mesenteric vessels (2). This equates to 1000 cm 
of cleft for each cm2 of venular wall, and 100 cm of open junction. The Lp in the mesenteric vessels is 
approximately 1.3x10-7 cm.s-1.cmH2O-1 and the net driving pressure (Hydrostatic minus Oncotic 
pressures) would be ~5 cmH2O (2, 3). If the EC intercellular cleft is 18 nm wide then (maintaining 
traditional units) the fluid velocity though these slits (V) is calculated to be 3.6x10-3 cm/s. 𝐷𝐶𝑙𝑒𝑓𝑡
𝑖  can 
be calculated through a slit (4, 5): 
𝐷𝐶𝑙𝑒𝑓𝑡
𝑖 = 𝐷𝐹𝑟𝑒𝑒
𝑖 [1 − 1.004𝐵 + 0.418𝐵3 + 0.210𝐵4 − 0.1696𝐵5]  EQ. 3 
Where: 
𝐵 = 2𝑎𝑖/𝑊𝐶𝑙𝑒𝑓𝑡      EQ. 4 
With 𝑎𝑖 as the molecular radius and 𝑊𝐶𝑙𝑒𝑓𝑡 as the cleft width. 
𝐷𝐶𝑙𝑒𝑓𝑡
𝑖  for a 10 kDa dextran in the cleft (𝐷𝐶𝑙𝑒𝑓𝑡
10 𝑘𝐷𝑎 𝑑𝑒𝑥𝑡𝑟𝑎𝑛) is calculated as 9.3x10-7 cm2.s-1, given an 18 
nm slit, assuming free diffusion of 1.1x10-6 cm2.s-1 (6) and a Stokes-Einstein radius of 2.3 nm 
(manufacturer datasheet). The estimated length of the cleft varies from 400 nm to nearer 1000 nm, 
but assuming a mean length of 700 nm (7) the estimate of Pe10 kDa dextran is 0.3.  
For comparison with albumin (using 3.5 nm for the radius (8) and 1.0x10-7 cm2.s-1 for free diffusion), 
Pe Albumin = 4. 
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Cremaster muscle vessels have not to date been analysed to the same detail but the tissue has 
previously been estimated to have between 5x and 10x lower Lp (9, 10). These experiments also 
noted that limiting pore sizes were unlikely to be the reason for the difference between muscle and 
mesenteric blood vessels, and therefore the available proportion of EC surface area was given as the 
most likely explanation. Intuitively, if we have only 10% of the available EC cleft area, the resistance 
is 10-fold higher (Lp is reduced by 10-fold) and would not change the 𝑃𝑒𝑖. However, the resistance 
from the endothelial glycocalyx in the mesenteric vessels is similar in magnitude (50% to 150%) to 
the EC cleft resistance, and therefore contributes between 33 and 67% of the total resistance across 
the vessel wall. This means that the available area of the cleft would need to be reduced by more 
than 10-fold (15-fold to 30-fold respectively) to produce a 10-fold reduction in Lp and hence the 𝑃𝑒𝑖 
must be greater in the case of cremaster vessels. In Supplemental Figure 4, we model 𝑃𝑒 for 10kDa 
dextran at different hydraulic conductivity and percent contribution of the glycocalyx to endothelial 
resistance. It can be seen that Pe10kDa rises from 0.3 in the mesentery (Lp ~ 1.3x10-7 cm.s-1.cmH2O-1) 
to between at least 0.4 and likely greater than 0.8 in the cremaster. Therefore the movement of a 
small molecular weight protein (e.g. a chemokine or 10 kDa dextran) back into the vasculature is likely 
to be finely balanced under normal conditions as the Pe10kDa dextran is approaching unity. 
Calculation of Pe10kDa during a hyperpermeability inflammatory response:  
The experimental results in this manuscript (see Figure 4) show that topical application of 10 kDa 
dextran to exteriorised cremaster muscles led to detection of a low level of this molecule in the 
vasculature under homeostatic conditions. This is in line with the preceding mathematical 
expectations. Upon addition of histamine, higher levels of 10 kDa dextran were detected in the 
vasculature, i.e. a decrease in Pe10kDa to substantively less than 1. Since the experiment also involved 
tracking i.v. injected 75 kDa dextran (used to represent an albumin sized molecule), which was 
correspondingly increased in the interstitium, these results indicate an increase in hydraulic flux. 
Clearly, any increase in water flux without a structural change in the cleft region would increase 𝑃𝑒𝑖 
rather than decrease it, strongly indicating that in these works a structural change to the vessel had 
been induced. The principal possibilities are changes to the endothelial glycocalyx or within the EC 
cleft region. 
An endothelial glycocalyx with a 100 nm thick filtration zone exhibiting 9 nm pores with 20 nm spacing 
has much lower 𝐷𝐺𝑙𝑥
𝑖 , but as its available surface area is markedly greater covering the whole EC cleft 
length and the EC cleft entrance (circa 200 nm wide), it may impact the hydraulic velocity within each 
pore by reducing it (11, 12). Using the above model for diffusion across the EC glycocalyx (using the 
𝐷𝑃𝑜𝑟𝑒
𝑖  versions of Equation 3 and 4), Pe10 kDa dextran = 0.004 and 0.002 in cremaster and mesenteric 
vessels respectively (Pe Albumin = 0.1 and 1 respectively) and as such indicates that 10 kDa dextran is 
completely diffusion dominant in the endothelial glycocalyx. These calculations strongly indicate that 
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in our experimental model the transport of a 10 kDa molecule from the tissue to the lumen is defined 
by the EC cleft component of the vessel wall and under increased permeability   
If histamine primarily changes the junctional strands in the cremaster exchange vessels, effectively 
increasing 𝐴𝑂𝑝𝑒𝑛 to that of the mesentery (or beyond), Pe
10 kDa dextran decreases from near unity to 0.3 
(or further). This change results in the 10 kDa dextran diffusion flux to be dominant and hence for the 
molecule to be far more capable of travelling from the interstitium to the vasculature, even in the 
presence of the increased hydraulic flux from the vessel to the interstitium.  
To comprehend the 75 kDa dextran (representing albumin sized molecules) flux increase one can 
use the effective solute permeability (𝑃𝑠). This has been derived numerous times by Curry’s group 
(13) and others, based on calculations by Patlak and colleagues (14): 
𝑃𝑠 =  (
𝑒𝑃𝑒
𝑒𝑃𝑒−1
) [𝐿𝑝(1 − 𝜎)∆𝑃]    EQ. 5 
Where the 𝜎 is the reflection coefficient, for albumin 𝜎𝐴𝑙𝑏𝑢𝑚𝑖𝑛 = 0.95 (15). Utilising our parameters for 
the endothelial cell glycocalyx, the primary albumin resistance, the effective permeability rises from 
3.3 x10-8 cm.s-1 to 5.0 x10-8 cm.s-1 for the transition from cremaster to mesenteric blood vessels. The 
tissue albumin concentration would therefore be expected to increase with the expected increase in 
junctional strand breaks, as observed by the increase in interstitial 75 kDa dextran. Of note is the 
sensitivity and dependence on Pe : increasing the ∆𝑃 by 5 cm.H2O will make a 1.5-fold change to the 
mesenteric effective permeability but only 1.05-fold to the cremaster. Our estimate here is low 
compared to experimental data that ranges from 0.4 x10-6 cm.s-1 to 3 x10-6 cm.s-1 but these have 
various other caveats namely that ∆𝑃 was higher, dramatically increasing the sensitive parameter Pe. 
Further the mathematical derivation, although not phenomenological, is simplistic for several reasons, 
in particular a perfect membrane of zero thickness. 
In conclusion, we have mathematically shown that in normal physiology, the diffusion of a 10 kDa 
molecule in the cremaster muscle tissue would be expected to be finely regulated. If the breaks in the 
EC junctional strands are more common, such as when induced by the inflammatory agent histamine 
that increases vascular permeability, then the tissue concentration of albumin sized molecules will be 
higher and at the same time, the 10 kDa molecule will be able to enter the vascular lumen. This 
mathematical prediction fits the experimental observations of the present study. 
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Supplemental Figure 5. VEGF promotes leakage of locally applied human CXCL8 from the 
tissue into the vascular compartment. Cremaster muscles were injected locally with IL-1 (50 ng) 
and human CXCL8 (hCXCL8, 500ng) for 1 h, followed by injection (i.v.) of vehicle (control) or VEGF 
(4 g) for a further 1 h. hCXCL8 levels in plasma as quantified by ELISA (n = 4-5 mice per group). 
Data are represented as mean ± SEM (each dot represents one mouse and one independent 
experiment). Statistically significant difference from vehicle is indicated by *p<0.05, two-tailed 
Student’s t-test. 
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Supplemental Figure 6. Effect of blocking anti-VE-PTP and anti-VE-cadherin antibodies on 
vascular leakage and chemokine level. (A-B) Cremaster muscles of WT mice were stimulated with 
IL-1 (50 ng for 2 h) followed by topical superfusion of histamine onto exteriorised tissues. Blocking 
anti-VE-PTP mAb (100-200 g) was injected i.v. 30 min before exteriorisation of tissues. Control mice 
received i.v. PBS or control rabbit IgG (no differences were observed between the 2 groups). 
Fluorescently-labelled anti-CD31 mAb was injected i.s. to visualise endothelial cell junctions and 75 
kDa TRITC-dextran was injected i.v. at the beginning of the image acquisition period to visualise and 
quantify vascular leakage. (A) Time-course of dextran accumulation in the perivascular region of 
selected stimulated post-capillary venules. Tissue dextran accumulation is represented as normalised 
MFI (n = 3-4 mice per group). (B) CXCL1 levels in plasma as quantified by ELISA (n = 4-5 mice per 
group). (C-D) Cremaster muscles of WT mice were injected i.s. with a blocking anti-VE-cadherin mAb 
(BV13, 100 g) for 4 h. Control mice were injected locally with PBS or anti-CD31 mAb (390, 100 g) 
(data pooled as no difference was noted between the groups) for 4 h. Thirty minutes before the end 
of the in vivo test period, mice were injected i.v. with red-(580/605)-microspheres (20 nm in diameter, 
9.1 x 1013 beads). Tissues were then collected and immunostained for anti-CD31 (clone 2H8, red) 
and analysed by confocal microscopy. (C) Representative confocal images of post-capillary venular 
segments from indicated reactions. Scale bars, 5 m. (D) Cremaster muscle vascular leakage as 
quantified by accumulation (MFI) of extravascular beads (n = 4 mice per group). Statistically significant 
difference from control is indicated by **p<0.01, two-tailed Student’s t-test.  
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Supplemental Figure 7. Further characterisation of the biotin-Ly6G-AF647-streptavidin in vivo 
labelling method. (A) LysM-EGFP-ki mice received an i.v. injection of biotin-Ly6G mAb (2 g) for 30 
min, after which cremaster muscles were exteriorised and superfused with AF647-streptavidin (1 
g/ml) in combination with histamine or vehicle for 2 h. Peripheral blood was collected and analysed 
by FACS with representative flow cytometry profiles showing the percentage of AF647-Streptavidin+ 
neutrophils presented (representative of 3 independent experiments). (B) Cremaster muscles of 
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LysM-EGFP-ki mice were stimulated with IL-1 (50 ng for 2 h) and the mice were injected i.v. with 
biotin-anti-Ly6G mAb (2 g) at t = 90 min. Blood was collected 2 h later and stained with AF647-strept 
in vitro to analyse the efficiency of biotinylated-anti-Ly6G labelling of circulating neutrophils. 
Representative flow cytometry profiles showing the percentage of AF647-Streptavidin+ neutrophils 
(representative of 5 independent experiments). (C and D) Cremaster muscles of WT mice were 
stimulated locally with IL-1 (50 ng) or PBS for 2 h and the mice were injected i.v. with biotin-anti-
Ly6G (2 g) at t = 90 min. The mice were then injected either with i.s. histamine (200l of 30 M 
solution) or PBS all in conjunction with AF647-streptavidin (400 ng) for 2 h. Tissues were then 
collected and immunostained for VE-cadherin (red) and MRP14 (neutrophil, green) and analysed by 
confocal microscopy. (C) Representative confocal images of post-capillary venular segments from 
indicated reactions (left panels) and (D) enlarged images of boxed regions where AF647-streptavidin 
staining is shown within neutrophil isosurface masks (representative of 3 independent experiments). 
Scale bars, 15 m (C) and 4 m (D).   
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Supplemental Figure 8. The biotin-Ly6G-AF647-streptavidin labelling strategy has no impact 
on neutrophil motility in vivo. Cremaster muscles of LysM-EGFP-ki mice were stimulated locally 
with IL-1 (50 ng for 1.5 h) followed by an i.v. injection of biotin-anti-Ly6G mAb (2 g) at t = 90 min. 
Tissues were then exteriorised and superfused with histamine (30 M) or vehicle in combination with 
AF647-streptavidin (1 g/ml) for 2 h. (A) Total neutrophil extravasation (n = 3 mice per group) and (B) 
frequency of neutrophil rTEM (n = 3-4 mice per group) show similar levels compared to reactions 
quantified in mice not subjected to the labelling strategy (see Figure 2A and D). (C and D) Mice 
subjected to the biotin-Ly6G-AF647-streptavidin labelling strategy and unlabelled mice exhibited 
similar neutrophil TEM duration (C, n = 3-9 mice per group) and neutrophil interstitial migration speed 
(D, n = 32-74 neutrophils per group) in cremaster muscles following local stimulation with IL-1 or IL-
1+histamine. Data are represented as mean ± SEM (each point represents one mouse and one 
independent experiment). Statistically significant differences from IL-1 are shown by *p<0.05, two-
tailed Student’s t-test.       
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Supplemental Figure 9. In mice subjected to a local hyperpermeability reaction blood AF647-
streptavidin+ neutrophils show a distinct activated phenotype and streptavidin+ neutrophils 
are present in the bone marrow at 4 h but not at 2 h post histamine. Cremaster muscles of WT 
mice were stimulated with IL-1 (50 ng) or PBS for 2 h followed by an i.s. injection of histamine (200 
l of 30 M solution) or PBS. Mice were subjected to our biotin-Ly6G-AF647-streptavidin labelling 
strategy and as such received an i.v. injection of biotin-anti-Ly6G mAb (2 g) at t = 90 min and were 
also injected locally with AF647-streptavidin (400 ng) in conjunction with histamine or vehicle for 2-4 
h. Peripheral blood, pulmonary vascular washout and bone marrow samples were collected and 
analysed by flow cytometry. (A) Representative flow cytometry histograms of blood neutrophils from 
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a mouse subjected to cremaster muscle stimulation with IL-1+histamine and biotin-Ly6G-AF647-
streptavidin labelling strategy 2 h post histamine. The sample is assessed for the indicated markers 
and comparing AF647-Streptavidin+ neutrophils with AF647-Streptavidin- neutrophils with relevant 
isotype control profiles being shown in black (representative of five independent experiments). (B) 
Frequency of blood AF647-Strept+ neutrophils (Gr-1high/CD115-) in mice subjected to the indicated 
cremasteric stimulations (n = 5-7 mice per group). (C) Frequency of pulmonary vascular washout 
AF647-Strept+ neutrophils (Gr-1high/CD115-) in mice subjected to the indicated cremasteric 
stimulations (n = 3-5 mice per group). (D)  Representative flow cytometry profiles and (E) frequency 
of bone marrow AF647-Strept+ neutrophils (Gr-1high/CD115-) in mice subjected to the indicated 
cremasteric stimulations (n = 5-6 mice per group). (F)  Representative flow cytometry profiles and (G) 
frequency of bone marrow AF647-Strept+ neutrophils (Gr-1high/CD115-) in mice subjected to the 
indicated cremasteric stimulations (n = 3-6 mice per group). Data are represented as mean ± SEM 
(each dot represents one mouse and one independent experiment). Statistically significant 
differences from PBS are shown by **p<0.01 or by indicated comparisons #p<0.05, ##p<0.01, one-
way ANOVA followed by Bonferroni’s post hoc test (ns = not significant). 
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Supplemental Figure 10. Blood and pulmonary vascular washout AF647-Streptavidin- 
neutrophils show a phenotype similar to that of control cells. WT mice were subjected to 
cremaster muscle stimulation with IL-1 (50 ng) or PBS for 2 h followed by i.v. injection of biotinylated-
anti-Ly6G (2 g) at t = 90 min. The mice then received an i.s. injection of AF647-Strept (400 ng) co-
administered with histamine (200 l of 30 M solution) or PBS for 2 hours. Peripheral blood and 
pulmonary vascular washout were collected and analysed by flow cytometry. (A and B) The 
phenotype of AF647-Streptavidin- neutrophils in blood and pulmonary vascular washout samples 
acquired from mice subjected to cremaster muscle stimulation with IL-1+histamine and the biotin-
Ly6G-AF647-streptavidin labelling strategy was compared to phenotype of neutrophils from 
unlabelled mice in which the cremaster muscles were stimulated locally with PBS, histamine and IL-
1 alone. Results are presented as gMFI fold change compared to the neutrophils of samples 
acquired from PBS-treated mice (n = 3-10 mice per group). Data are represented as mean ± SEM 
(each dot represents one mouse and one independent experiment). No statistical differences were 
obtained between any of the groups and PBS, one-way ANOVA followed by Bonferroni’s post hoc 
test.  
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Supplemental movie legends 
  
Supplemental movie 1 (related to Figure 1A). Microvascular leakage and neutrophil TEM in an 
IR-stimulated cremaster muscle. The movie captures a post-capillary venule after 40 min of 
ischemia in a LysM-EGFP-ki mouse. EC junctions were labelled in vivo with an AF647-anti-CD31 
mAb (red). 75 kDa TRITC-dextran was injected i.v. 2 min after the beginning of the acquisition. The 
video shows luminal views of GFPbright neutrophils (green) interacting with ECs (left panel) and 
trafficking of vascular dextran (blue pseudocolor intensity; right panel). The movie illustrates the 
development of an inflammatory response during IR with neutrophils breaching EC junctions and the 
occurrence of rapid and localised areas of intravascular dextran leakage (exemplified by boxed 
regions). Dextran signal was smoothed using a Gaussian filter for clarity using Imaris software. Still 
images of this video are shown in Figure 1A.   
 
Supplemental movie 2 (related to Figure 1D). Neutrophil normal TEM in an IR-stimulated 
cremaster muscle. The confocal IVM movie shows a cremaster muscle post-capillary venule of a 
LysM-EGFP-ki mouse in which the TEM of a GFPbright neutrophil is tracked during reperfusion phase 
of an IR reaction. EC junctions were labelled in vivo with an AF647-anti-CD31 mAb (red). In addition, 
75 kDa TRITC-dextran was injected i.v. 2 min after the beginning of the acquisition; the signal was 
removed from the video for clarity. The video shows luminal views and the cross section of a selected 
neutrophil in high optical magnification undergoing TEM. The neutrophil was isolated from the 
inflammatory response for improved clarity by creating an isosurface using Imaris software. Still 
images of this video are shown in Figure 1D.   
 
Supplemental movie 3 (related to Figure 1D). Neutrophil reverse TEM in an IR-stimulated 
cremaster muscle. The confocal IVM movie shows an IR injury response of a cremaster muscle 
post-capillary venule in a LysM-EGFP-ki mouse. The movie tracks GFPbright neutrophils (green) during 
the reperfusion phase with EC junctions being labelled in vivo with an AF647-anti-CD31 mAb (red). 
The video shows luminal views and the cross section of a selected neutrophil. The neutrophil that is 
initially on the luminal side of the endothelium, transmigrates into the sub-EC space and subsequently 
migrates through EC junctions back into the vascular lumen, i.e. exhibits reverse TEM and re-enters 
the blood circulation. The neutrophil was isolated from the inflammatory response by creating an 
isosurface using Imaris software for clarity. Still images of this video are shown in Figure 1D.  
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Supplemental movie 4 (related to Figure 2B). Microvascular leakage and neutrophil reverse 
TEM as induced by IL-1 and topical histamine. The movie captures a cremaster muscle post-
capillary venule in a LysM-EGFP-ki mouse in which GFPbright neutrophils (green) are tracked post local 
treatment with IL-1 and topical histamine (30 M). EC junctions were labelled in vivo with an AF647-
anti-CD31 mAb (red). In addition, 75 kDa TRITC-dextran (blue pseudocolor intensity) was injected 
i.v. 3 min after the beginning of the image acquisition. The first part of the video shows the 
development of an inflammatory response illustrating luminal neutrophil-EC interactions. In addition, 
the video shows dextran extravasation after the topical application of histamine. The second part of 
the video shows high magnification images of a selected neutrophil within the same vessel segment 
undergoing reverse TEM. The neutrophil which is already in the sub-EC space migrates through EC 
junction in an abluminal-to-luminal direction. Dextran signal was smoothed using a Gaussian filter and 
the neutrophil was isolated from the inflammatory response by creating an isosurface using Imaris 
software for clarity. Still images of this video are shown in Figure 2B. 
 
Supplemental movie 5 (related to Figure 4E). Interstitial 10 kDa AF488-dextran traffics through 
leaky venules into the blood stream. The movie shows a post-capillary venule in a WT mouse 
locally stimulated with IL-1. EC junctions were labelled in vivo with an AF647-anti-CD31 mAb (blue). 
75 kDa TRITC-dextran (red) was injected i.v. 2 min and 10 kDa AF488-dextran (green) was 
superfused 7 min after the beginning of the image acquisition. At t = 17 min, 10 kDa AF488-dextran 
was removed from the superfusate and replaced by Tyrode’s solution containing 30 M histamine. 
For clarity, EC junctions and 75 kDa TRITC-dextran signals are shown on the left side and during the 
first part of the video. Similarly, EC junctions and 10 kDa AF488-dextran are shown on the right side 
and during the second part of the video. Collectively the movie shows that immediately after topical 
histamine the intravascular 75 kDa TRITC-dextran rapidly leaks into the perivascular space (indicative 
of enhanced vascular leakage) while free flowing interstitial 10 kDa AF488-dextran disappears from 
the tissue compartment (or is captured by perivascular cells). Dextran signals were smoothed using 
a Gaussian filter for clarity using Imaris software. Still images of this video are shown in Figure 4E. 
 
Supplemental movie 6 (related to Figure 7C). Topical AF647-streptavidin efficiently labels 
rTEM neutrophils. LysM-EGFP-ki mice were stimulated with IL-1 (50 ng for 2 h) followed by an i.v. 
injection of biotin-anti-Ly6G mAb (2 g) to label blood neutrophils at t = 90 min. Tissues were then 
exteriorised and superfused with histamine (30 M) in conjunction with AF647-streptavidin (1 g/ml) 
for 2 h. The movie tracks GFPbright neutrophils (blue) during the vascular leakage phase induced by 
histamine with EC junctions being labelled in vivo with an AF555-anti-CD31 mAb (green). The tracked 
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neutrophil that is initially on the luminal side of the endothelium, initiates TEM and during this process 
its leading body within the sub-EC space rapidly becomes AF647-Strept+. When the neutrophil 
reverse migrates through EC junctions and re-enters the vascular lumen, AF647-streptavidin quickly 
redistributes around the surface of the cell and hence the rTEM neutrophil is effectively labelled as 
AF647-Strept+. The neutrophil was isolated from the inflammatory response by creating an isosurface 
using Imaris software for clarity. Still images of this video are shown in Figure 7C.   
